Hsp40 and conformational disease
Hsp40 and conformational disease
批准号:
8011299
负责人:
DOUGLAS M CYR
金额:
$28.3万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2012-11-30
关键词:
AddressAmyloidBiological AssayCaringCell DeathCellsDataDementiaDiseaseDoctor of PhilosophyGrantMolecular ChaperonesMonitorNerve DegenerationNeurodegenerative DisordersPaperPathway interactionsPrionsProteinsPublished CommentReadingSpecific qualifier valueStructureStudy SectionTimeToxic effectWorkamyloid fibril formationamyloid formationdesigninterestmemberprion biogenesisprofessorprotein foldingtherapeutic targetyeast prion
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Conformational diseases are neurodegenerative maladies in which the accumulation of amyloid-like fibrillar forms of aberrantly folded proteins cause dementia and cell death via unknown mechanisms. Hsp40s are molecular chaperones that direct Hsp70 to interact with disease related proteins and partition them between pathways for folding, aggregation and amyloid formation. Prions are infectious proteins that that assemble into a self-perpetuating amyloid-like state that is associated with neurodegeneration. The study of yeast prions has provided many of the basic details about chaperone function in amyloid fibril formation. In preliminary studies we developed a number of assays to monitor Hsp40 action in modulating amyloid formation and toxicity. The studies proposed herein are designed to define mechanisms by which aberrant prion biogenesis causes cell death. In addition, we seek to identify the specific steps in prion assembly that are catalyzed by different Hsp40s. Finally, we will determine the structure and functional features of Type I and II Hsp40 sub-types that specify their action in prion biogenesis. The data obtained from these studies will define the rules for Hsp40 function in amyloid formation and identify therapeutic targets for the treatment of conformational disease.
Conformational diseases are a neurodegenerative maladies in which the accumulation of amyloid-like fibrillar forms of aberrantly folded proteins cause deimentia and cell death via unknown mechanisms. The data obtained from the proposed studies will define the rules for Hsp40 function in modulation of amyloid formation and toxicity and identify therapeutic targets for the treatment of conformational disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hsp40 and Hsp70 in Membrane Protein Triage
-
批准号:10718226
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2023
-
负责人:DOUGLAS M CYR
-
依托单位:
Detection of folding defects in mutant CFTR by ERQC
-
批准号:7925382
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2009
-
负责人:DOUGLAS M CYR
-
依托单位:
MECHANISMS FOR SPECIFICATION OF HSP40 FUNCTION
-
批准号:7049278
-
项目类别:
-
资助金额:$3.94万
-
财政年份:2006
-
负责人:DOUGLAS M CYR
-
依托单位:
MECHANISMS FOR SPECIFICATION OF HSP40 FUNCTION
-
批准号:7359623
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2006
-
负责人:DOUGLAS M CYR
-
依托单位:
MECHANISMS FOR SPECIFICATION OF HSP40 FUNCTION
-
批准号:7173853
-
项目类别:
-
资助金额:$3.82万
-
财政年份:2006
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and Stress Protection
-
批准号:6889993
-
项目类别:
-
资助金额:$25.37万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and conformational disease
-
批准号:7380260
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and Stress Protection
-
批准号:7052124
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and Stress Protection
-
批准号:6744186
-
项目类别:
-
资助金额:$25.37万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and conformational disease
-
批准号:7548135
-
项目类别:
-
资助金额:$32.65万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and conformational disease
-
批准号:7737661
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and Stress Protection
-
批准号:6599047
-
项目类别:
-
资助金额:$25.37万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
CHAPERONES AND THE BIOGENESIS OF MEMBRANE PROTEINS
-
批准号:6474958
-
项目类别:
-
资助金额:$14.51万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Detection of folding defects in mutant CFTR by ERQC
-
批准号:7340193
-
项目类别:
-
资助金额:$31.1万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Recognition of Defective CFTRdeltaF508 by Quality Control Machines
-
批准号:8457088
-
项目类别:
-
资助金额:$32.86万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Detection of folding defects in mutant CFTR by ERQC
-
批准号:7576083
-
项目类别:
-
资助金额:$31.1万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
CHAPERONES AND THE BIOGENESIS OF MEMBRANE PROTEINS
-
批准号:2857347
-
项目类别:
-
资助金额:$18.93万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Chaperones and membrane protein biogenesis
-
批准号:7003806
-
项目类别:
-
资助金额:$28.6万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Recognition of Defective CFTRdeltaF508 by Quality Control Machines
-
批准号:8653961
-
项目类别:
-
资助金额:$34.05万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
CHAPERONES AND THE BIOGENESIS OF MEMBRANE PROTEINS
-
批准号:2464866
-
项目类别:
-
资助金额:$20.89万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
-
批准号:22077118
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:高楠
-
依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
-
批准号:81870666
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:王海燕
-
依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
-
批准号:81601123
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:都瑾
-
依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
-
批准号:30971012
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:刘瑞田
-
依托单位:
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
-
批准号:30570622
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2005
-
负责人:刘瑞田
-
依托单位: